Journal Article

Landscape of pathogenic variations in a panel of 34 genes and cancer risk estimation from 5131 HBOC families

Goardon, Nicolas, Domin, Florian, Quesnelle, Céline, Paimparay, Germain, Abadie, Caroline, Brault, Baptiste, Fouillet, Robin, Rousselin, Antoine, San, Chankannira, Béra, Odile, Berthet, Pascaline, Krieger, Sophie, Muller, Etienne, Legros, Angelina, Castéra, Laurent, Ricou, Agathe, Bruet, Olivia, Harter, Valentin, Vaur, Dominique, Frébourg, Thierry

2018

Overview

Integration of gene panels in the diagnosis of hereditary breast and ovarian cancer (HBOC) requires a careful evaluation of the risk associated with pathogenic or likely pathogenic variants (PVs) detected in each gene. Here we analyzed 34 genes in 5131 suspected HBOC index cases by next-generation sequencing. Using the Exome Aggregation Consortium data sets plus 571 individuals from the French Exome Project, we simulated the probability that an individual from the Exome Aggregation Consortium carries a PV and compared it to the estimated frequency within the HBOC population. Odds ratio conferred by PVs within BRCA1, BRCA2, PALB2, RAD51C, RAD51D, ATM, BRIP1, CHEK2, and MSH6 were estimated at 13.22 [10.01–17.22], 8.61 [6.78–10.82], 8.22 [4.91–13.05], 4.54 [2.55–7.48], 5.23 [1.46–13.17], 3.20 [2.14–4.53], 2.49 [1.42–3.97], 1.67 [1.18–2.27], and 2.50 [1.12–4.67], respectively. PVs within RAD51C, RAD51D, and BRIP1 were associated with ovarian cancer family history (OR = 11.36 [5.78–19.59], 12.44 [2.94–33.30] and 3.82 [1.66–7.11]). PALB2 PVs were associated with bilateral breast cancer (OR = 16.17 [5.48–34.10]) and BARD1 PVs with triple-negative breast cancer (OR = 11.27 [3.37–25.01]). Burden tests performed in both patients and the French Exome Project population confirmed the association of PVs of BRCA1, BRCA2, PALB2, and RAD51C with HBOC. Our results validate the integration of PALB2, RAD51C, and RAD51D in the diagnosis of HBOC and suggest that the other genes are involved in an oligogenic determinism.

• Publisher: Elsevier Inc,Nature Publishing Group US,Elsevier Limited,Nature Publishing Group
• Subject: Adult / Biomedical and Life Sciences / Biomedicine / BRCA1 Protein - genetics / BRCA2 Protein - genetics / Breast cancer / Consortia / DNA-Binding Proteins - genetics / Fanconi Anemia Complementation Group N Protein - genetics / France - epidemiology / Genes / Genetic Predisposition to Disease / genetic risk estimation / Genetic Testing / Genetic Variation - genetics / HBOC / Hereditary Breast and Ovarian Cancer Syndrome - diagnosis / Hereditary Breast and Ovarian Cancer Syndrome - epidemiology / Hereditary Breast and Ovarian Cancer Syndrome - genetics / Hereditary Breast and Ovarian Cancer Syndrome - pathology / High-Throughput Nucleotide Sequencing / Human Genetics / Human health and pathology / Humans / Laboratory Medicine / Life Sciences / Middle Aged / Neoplasm Proteins - genetics / Ovarian cancer / panel gene sequencing / Risk Factors / Whole Exome Sequencing